Ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae carrying multiple metallo-beta-lactamase genes

Indian Journal of Pathology and Microbiology

Volumn 52, Issue 3, 2009, Pages 339-342

  Dwivedi, Mayank ^a   Mishra, Anshuman ^b   Azim, Afzal ^a   Singh, R K ^a   Baronia, A K ^a   Prasad, K N ^a   Dhole, T N ^a   Dwivedi, U N ^b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF LUCKNOW   (India)

Author keywords

Carbapenem resistance; Enterobacter aerogenes; Enterobacteriaceae; Klebsiella pneumoniae; Metallo beta lactamase; Ventilator associated pneumonia

Indexed keywords

CARBAPENEM; METALLO BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; ENTEROBACTERIACEAE; GENOTYPE; HUMAN; INDIA; INTENSIVE CARE UNIT; LUNG LAVAGE; MAJOR CLINICAL STUDY; NONHUMAN; PHENOTYPE; TERTIARY HEALTH CARE; TRACHEAL ASPIRATION PROCEDURE; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; INDIA; INTENSIVE CARE UNITS; INTERSPERSED REPETITIVE SEQUENCES; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, VENTILATOR-ASSOCIATED;

EID: 70249138392     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: 10.4103/0377-4929.54988     Document Type: Article

References (23)

1. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
2. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: A systematic review. Crit Care Med 2005;33: 2184-2193
3. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115-2121
4. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-474
5. Kollef MH. Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients. Clin Infect Dis 2000;31:S131-8.
6. Rello J, Gallego M, Mariscal D, Sonora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997;156:196-200. (Pubitemid 27293188)
7. Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J, Jolly EC, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997;111:676-685 (Pubitemid 27132946)
8. Wu CL, Yang DIe, Wang NY, Kuo HT, Chen PZ. Quantitative culture of endotracheal aspirates in the diagnosis of ventilator-associated pneumonia in patients with treatment failure. Chest 2002;122:662-668
9. Clinical Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. 9th ed. Vol.26. 2006. p. M2-A9.
10. Lee JH, Choi CH, Kang HY, Lee JY, Kim J, Lee YC, et al. Differences in phenotypic and genotypic traits against antimicrobial agents between cinetobacter baumannii and Acinetobacter genomic species 13TU. Antimicrob Chemother 2007;59:633-639
11. Franklin C, Liolios L, Peleg AY. Phenotypic detection of carbapenem- susceptible metallo-beta-lactamase-producing gram-negative bacilli in the clinical laboratory. J Clin Microbiol 2006;44:3139-3144
12. Ellington MJ, Kistler J, Livermore DM, Woodford N. Multiplex PCR for apid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother 2007;59:321-322
13. Helfand MS, Bonomo RA. Current challenges in antimicrobial chemotherapy: the impact of extended-spectrum beta-lactamases and metallo-beta-lactamases on the treatment of resistant Gram-negative pathogens. Curr Opin Pharmacol 2005;5:452-458
14. Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002;8:321-331
15. Laupland KB, Parkins MD, Church DL, Gregson DB, Louie TJ, Conly JM, et al. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health egion: importance of metallo-beta-lactamase (MBL)-producing strains. J Infect Dis 2005;192:1606-1612
16. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev 2005;18:306-325
17. Livermore DM, Woodford N. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol 2006;14:413-420
18. Eisenstein BZ, DF, Enterobacteriaceae. 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000.
19. Paterson DL, Doi Y. A step closer to extreme drug resistance (XDR) in gram-negative bacilli. Clin Infect Dis 2007;45:1179-1181
20. Tato M, Coque TM, Ruíz-Garbajosa P, Pintado V, Cobo J, Sader HS, et al. complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? Clin Infect Dis 2007;45:1171-1178
21. Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 2005;165:1430-1435
22. Peleg AY, Franklin C, Bell JM, Spelman DW. Dissemination of the metallo- beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia. Clin Infect Dis 2005;41:1549-1556
23. Fukigai S, Alba J, Kimura S, Iida T, Nishikura N, Ishii Y, et al. Nosocomial outbreak of genetically related IMP-1 beta-lactamase-producing Klebsiella pneumoniae in a general hospital in Japan. Int J Antimicrob Agents 2007;29:306-310